Clinical Trials

Showing trials with last updates posted in 2026.

NCT06943872 | RECRUITING | PHASE3
630 participants

A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-24
Start Date:
2025-06-11
Completion:
2029-09-30
Conditions
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
Interventions
  • DRUG
No Results Yet
NCT06907524 | RECRUITING | NA
200 participants

Preventative Screening and Health Coaching in a Food Insecure Population

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-24
Start Date:
2025-03-01
Completion:
2027-04-01
Conditions
  • Cardiovascular Disease Prevention
  • Cardiometabolic Diseases
  • Cardiovascular Risk Factor
  • Cardiovascular Risk Score
  • Hypertension
  • Hyperlipidemia
  • Diabetes
  • Lifestyle Modification
  • Health Coaching
Interventions
  • BEHAVIORAL
No Results Yet
NCT06770582 | RECRUITING | PHASE2
160 participants

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-24
Start Date:
2025-06-03
Completion:
2032-02-01
Conditions
  • Non-Muscle Invasive Bladder Urothelial Carcinoma
  • Recurrent Non-Muscle Invasive Bladder Urothelial Carcinoma
  • Stage I Bladder Cancer AJCC v8
Interventions
  • PROCEDURE
  • DRUG
  • BIOLOGICAL
  • OTHER
  • RADIATION
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page